Lucid Diagnostics Inc
LUCDHealthcare·Medical Devices·USA·Micro·NASD·Nov 13 • 8:04 AM ET
0.41-0.01 (-1.68%)
2026-11-13 14:04 CET
Market cap
$83.09M
Revenue, TTM
5.44 USD m
Net income, TTM
-61.29 USD m
Free cash flow, TTM
-51.83 USD m
EPS diluted, TTM
-0.41
Price
LUCD against its 20, 50 and 200-day averagesPatternshover a marker to name it
74.9% under the 52-week high of 1.63 on 21 Jan 2026. 52-week low 0.30 on 20 Oct 2026. Last 15 sessions, 50.1% high to low
Volume 0.03× normal · the line is the 50-bar volume average
Setup. RS line 0
CANSLIM 3 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Float: Under 100M; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
LUCD52-week range, 8% of the way up
0.301.63
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
| Index | RUT |
|---|---|
| Employees | 82 |
| IPO | Oct 14, 2021 |
| Beta | 1.16 |
| ATR, 14d | 0.05 |
| Rel volume | 0.03 |
| Short float | 9.36% |
| Insider own | 21.20% |
| Inst own | 29.83% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $83.09M |
| Enterprise Value | 83.59M |
| Income | -61.29M |
| Sales | 5.44M |
| Book / share | 0.03 |
| Cash / share | 0.09 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 82 |
| IPO | Oct 14, 2021 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 15.27 |
| Price / book | 13.16 |
| Price / cash | 4.62 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 15.37 |
| Quick Ratio | 1.16 |
| Current Ratio | 1.20 |
| Debt / equity | 3.12 |
| Long-term debt / equity | 0.05 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -0.41 |
|---|---|
| Earnings next year | -0.18 |
| Earnings next quarter | -0.06 |
| Earnings this year | 37.21% |
| Earnings next year | 31.48% |
| Earnings growth, 5 years | 28.07% |
| Past earnings growth | 23.61% -25.34% |
| Past sales growth | 131.97% - |
| Earnings vs last year | 55.16% |
| Sales vs last year | 23.60% |
| Earnings vs last quarter | 63.58% |
| Sales vs last quarter | -0.66% |
| Earnings | Nov 12 BMO |
| Surprise | -4.35% -26.25% |
Ownership
| Insiders own | 21.20% |
|---|---|
| Insider trades | 0.57% |
| Institutions own | 29.83% |
| Institution trades | 16.43% |
| Return on assets | -119.77% |
| Return on equity | -305.59% |
| Return on capital | -781.50% |
| Gross Margin | -32.68% |
| Operating margin | -941.73% |
| Profit Margin | -1127.20% |
| 20-day average | 1.42% |
| 50-day average | -31.87% |
| 200-day average | -58.50% |
Technical
| Shares out | 190.97M |
|---|---|
| Shares floating | 160.15M |
| Short / float | 9.36% |
| Short ratio | 3.03 |
| Short interest | 14.99M |
| 52-week high | 1.63 -74.9% |
| 52-week low | 0.30 +35.0% |
| Volatility | 9.13% 15.66% |
| Average range | 0.05 |
| Strength index | 41.52 |
| Market sensitivity | 1.16 |
| Relative volume | 0.03 |
| Avg Volume | 4.95M |
| Volume | 6,250 |
Performance
| Perf Week | 2.71% |
|---|---|
| Perf Month | -21.40% |
| Perf Quarter | -58.19% |
| Perf Half Y | -58.75% |
| Perf YTD | -62.50% |
| Perf Year | -61.79% |
| Perf 3Y | -64.76% |
| Perf 5Y | -95.82% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 4.00 |
| Prev Close | 0.42 |
| Price | 0.41 |
| Change % | -1.80% |
Analyst ratings
latest 4 of 4| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Dec 27, 2021 | Initiated | Ascendiant Capital Markets | Buy | $16 | +3,813.9% |
| Nov 08, 2021 | Initiated | Needham | Buy | $17 | +4,058.5% |
| Nov 08, 2021 | Initiated | Cantor Fitzgerald | Overweight | $21 | +5,037.0% |
| Nov 08, 2021 | Initiated | BTIG Research | Buy | $14 | +3,324.7% |
Peers
Mkt capInsider trading
1 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director | May 20 '26 | Buy | 1.00 | 245,000 | 245,270 | 1,033,443 | May 21 04:20 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
| VTWG | Vanguard Russell 2000 Growth Index ETF | AUM: 1.43B |
| RSSL | Global X Russell 2000 ETF | AUM: 1.44B |
| VTHR | Vanguard Russell 3000 Index ETF | AUM: 4.87B |
| ITWO | ProShares Russell 2000 High Income ETF | AUM: 179.79M |
News
latest 14 of 100- PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results (PR Newswire)
- Lucid Diagnostics Matches The Whisper But Misses On Revenue As Medicare Payments Reset The Story, And Dilution Raises The Price Of Admission (Earnings Whispers) +9.15%
- Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results (PR Newswire)
- Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year (PR Newswire) -12.36%
- Lucid Diagnostics Needs Proof Its Paid-Test Pivot Can Outrun A Shrinking Cash Pile (Earnings Whispers) +8.83%
- Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
- Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard Study (PR Newswire)
- PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 (PR Newswire) -6.36%
- Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026 (PR Newswire) +5.03%
- Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard and Closes $15 Million Financing (PR Newswire) +25.42%
- Lucid Diagnostics Advances Multiple EsoGuard and EsoCheck Payment, Billing and Coding Pathways (PR Newswire) +5.62%
- PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results (PR Newswire)
- Lucid Diagnostics Inc (LUCD) (Q2 2026) Earnings Call Highlights: Strategic Pivot to High-Value ... (GuruFocus.com)
- Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results (PR Newswire)
Quarterly earnings
2026Q3 EPS -0.060 missed -0.058, from -0.100 a year earlier. Sales 1.20 missed 1.63, from 1.21 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-12 08:30 | -0.060 | -0.058 | -0.035 | 1.20 | 1.63 | EPS +4.3% · sales -26.2% | vs 2025Q3, year-ago quarter · EPS -40.0% · sales -0.7% | 4 EPS · 5 sales | Open +4.88% vs SPY -0.77%. Close +9.15% vs SPY -0.35% |
| 2026Q2ended 2026-06-30 | 2026-08-13 08:30 | -0.060 | -0.057 | -0.080 | 1.47 | 1.43 | EPS +5.8% · sales +3.3% | vs 2025Q2, year-ago quarter · EPS -40.0% · sales +26.7% | 3 EPS · 5 sales | Open -0.45% vs SPY +0.31%. Close -1.98% vs SPY +0.70% |
| 2026Q1ended 2026-03-31 | 2026-05-14 08:30 | -0.070 | -0.063 | -0.169 | 1.26 | 1.38 | EPS +10.6% · sales -9.0% | vs 2025Q1, year-ago quarter · EPS -56.3% · sales +51.7% | 3 EPS · 5 sales | Open -0.98% vs SPY +0.18%. Close 0.00% vs SPY +0.79% |
| 2025Q4ended 2025-12-31 | 2026-03-26 08:30 | -0.100 | -0.093 | -0.124 | 1.50 | 1.36 | EPS +8.1% · sales +10.4% | vs 2024Q4, year-ago quarter · EPS -47.4% · sales +25.6% | 4 EPS · 5 sales | Open 0.00% vs SPY -0.72%. Close -3.36% vs SPY -1.79% |
| 2025Q3ended 2025-09-30 | 2025-11-12 08:30 | -0.100 | -0.095 | -0.096 | 1.21 | 1.35 | EPS +5.3% · sales -10.5% | vs 2024Q3, year-ago quarter · EPS -50.0% · sales +3.3% | 4 EPS · 6 sales | Open 0.00% vs SPY +0.26%. Close +6.73% vs SPY +0.06% |
| 2025Q2ended 2025-06-30 | 2025-08-13 08:30 | -0.100 | -0.114 | -0.080 | 1.16 | 1.16 | EPS -12.3% · sales +0.4% | vs 2024Q2, year-ago quarter · EPS -50.0% · sales +19.2% | 5 EPS · 6 sales | Open +2.26% vs SPY +0.35%. Close -1.64% vs SPY +0.34% |
| 2025Q1ended 2025-03-31 | 2025-05-14 08:30 | -0.160 | -0.148 | -0.524 | 0.83 | 1.28 | EPS +8.1% · sales -35.3% | vs 2024Q1, year-ago quarter · EPS -83.8% · sales -18.0% | 5 EPS · 6 sales | Open -5.04% vs SPY +0.17%. Close +7.56% vs SPY +0.13% |
| 2024Q4ended 2024-12-31 | 2025-03-24 08:30 | -0.190 | -0.178 | -0.198 | 1.20 | 1.43 | EPS +6.7% · sales -16.2% | vs 2023Q4, year-ago quarter · EPS -85.7% · sales +14.1% | 5 EPS · 6 sales | Open +1.32% vs SPY +1.21%. Close -1.32% vs SPY +1.79% |
| 2024Q3ended 2024-09-30 | 2024-11-13 08:30 | -0.200 | -0.206 | -0.246 | 1.17 | 1.14 | EPS -2.9% · sales +3.1% | vs 2023Q3, year-ago quarter · EPS -9.1% · sales +49.7% | 5 EPS · 6 sales | Open +10.00% vs SPY +0.08%. Close +5.00% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-12 08:30 | -0.200 | -0.200 | -0.228 | 0.98 | 1.22 | EPS 0.0% · sales -20.2% | vs 2023Q2, year-ago quarter · EPS -13.0% · sales +513.8% | 5 | Open +2.53% vs SPY +0.23%. Close +6.33% vs SPY +0.05% |
| 2024Q1ended 2024-03-31 | 2024-05-13 08:30 | -0.990 | -0.240 | -0.402 | 1.01 | 1.05 | EPS +312.5% · sales -3.6% | vs 2023Q1, year-ago quarter · EPS +312.5% · sales +126.5% | 5 EPS · 6 sales | Open +0.59% vs SPY +0.33%. Close +0.59% vs SPY +0.01% |
| 2023Q4ended 2023-12-31 | 2024-03-26 16:30 | -1.330 | -0.230 | -0.256 | 1.05 | 1.04 | EPS +478.3% · sales +0.9% | vs 2022Q4, year-ago quarter · EPS +303.0% · sales +836.6% | 1 | Open 0.00% vs SPY +0.56%. Close 0.00% vs SPY +0.84% |
| 2023Q3ended 2023-09-30 | 2023-11-13 16:30 | -0.220 | -0.238 | -0.339 | 0.78 | 0.80 | EPS -7.4% · sales -2.1% | vs 2022Q3, year-ago quarter · EPS -21.4% · sales +930.3% | 4 EPS · 5 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-14 16:30 | -0.230 | -0.283 | -0.272 | 0.16 | 0.62 | EPS -18.6% · sales -74.4% | vs 2022Q2, year-ago quarter · EPS -43.9% · sales - | 4 EPS · 5 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-15 16:30 | -0.240 | -0.325 | -0.397 | 0.45 | 0.24 | EPS -26.2% · sales +86.8% | vs 2022Q1, year-ago quarter · EPS +4.3% · sales +136.0% | 5 | - |
| 2022Q4ended 2022-12-31 | 2023-03-13 16:30 | -0.330 | -0.330 | -0.400 | 0.11 | 0.34 | EPS 0.0% · sales -67.2% | vs 2021Q4, year-ago quarter · EPS +50.0% · sales -62.7% | 4 EPS · 5 sales | - |
Annual earnings
2025FY EPS -0.430 beat -0.575, from -0.790 a year earlier. Sales 4.71 beat 4.56, from 4.35 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | -0.070 | - | - | 52.10 | - |
| 2029FYestimate | - | -0.090 | - | - | 36.80 | - |
| 2028FYestimate | - | -0.160 | - | - | 33.11 | - |
| 2027FYestimate | - | -0.185 | - | - | 16.31 | - |
| 2026FYestimate | - | -0.270 | - | - | 6.03 | - |
| 2025FY | -0.430 | -0.575 | -0.690 | 4.71 | 4.56 | - |
| 2024FY | -0.790 | -0.910 | -1.050 | 4.35 | 4.57 | - |
| 2023FY | -5.780 | -0.920 | -1.261 | 2.45 | 2.43 | - |
| 2022FY | -1.080 | -1.218 | -1.553 | 0.38 | 0.58 | - |
| 2021FY | -0.960 | -1.215 | -0.804 | 0.50 | 0.50 | - |
Quarterly results
2026Q3 revenue 1.20, from 1.21 a year earlier. Operating margin -1,023%, from -971.9% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026Q4 E -0.06 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026Q4 | E | per share | 2026-11-12 | -0.06 | 0.0% |
| 2026FY | R | per share | 2026-11-12 | -0.32 | -6.4% |
| 2026Q4 | R | per share | 2026-11-12 | -0.06 | -1.3% |
| 2026FY | S | per share | 2026-11-12 | 6.03 | -4.4% |
| 2026Q4 | S | per share | 2026-11-12 | 1.90 | -2.4% |
| 2026FY | E | per share | 2026-11-09 | -0.27 | 0.0% |
| 2026Q3 | E | per share | 2026-11-09 | -0.06 | 0.0% |
| 2026Q3 | S | per share | 2026-11-09 | 1.63 | 0.0% |
| 2026Q3 | R | per share | 2026-11-06 | -0.06 | -1.0% |
| 2026Q2 | E | per share | 2026-08-07 | -0.06 | +6.4% |
| 2026Q2 | R | per share | 2026-07-28 | -0.07 | 0.0% |
| 2026Q2 | S | per share | 2026-07-28 | 1.43 | 0.0% |
| 2026Q1 | E | per share | 2026-05-14 | -0.06 | -13.1% |
| 2026Q1 | R | per share | 2026-05-14 | -0.08 | -1.5% |
| 2026Q1 | S | per share | 2026-05-14 | 1.33 | -3.3% |
| 2025FY | E | per share | 2026-03-26 | -0.81 | +31.3% |
| 2025Q4 | E | per share | 2026-03-26 | -0.11 | +22.2% |
| 2025FY | R | per share | 2026-03-26 | -0.79 | +5.8% |
| 2025Q4 | R | per share | 2026-03-26 | -0.09 | -6.9% |
| 2025FY | S | per share | 2026-03-26 | 4.60 | +1.1% |
| 2025Q4 | S | per share | 2026-03-26 | 1.40 | +3.7% |
| 2025Q3 | E | per share | 2025-11-07 | -0.10 | +5.3% |
| 2025Q3 | S | per share | 2025-11-07 | 1.35 | +0.0% |
| 2025Q3 | R | per share | 2025-10-27 | -0.11 | 0.0% |
| 2025Q2 | R | per share | 2025-08-11 | -0.11 | 0.0% |
| 2025Q2 | S | per share | 2025-08-11 | 1.16 | +0.1% |
| 2025Q2 | E | per share | 2025-07-28 | -0.11 | 0.0% |
| 2025Q1 | E | per share | 2025-05-09 | -0.15 | +2.8% |
| 2025Q1 | S | per share | 2025-05-09 | 1.28 | +0.4% |
| 2025Q1 | R | per share | 2025-04-09 | -0.15 | +0.2% |
| 2024FY | E | per share | 2025-03-24 | -0.81 | -11.0% |
| 2024Q4 | E | per share | 2025-03-24 | -0.16 | -12.9% |
| 2024FY | R | per share | 2025-03-24 | -0.87 | -5.8% |
| 2024Q4 | R | per share | 2025-03-24 | -0.17 | -6.3% |
| 2024FY | S | per share | 2025-03-24 | 4.61 | +0.9% |
| 2024Q4 | S | per share | 2025-03-24 | 1.46 | +2.3% |
| 2024Q3 | E | per share | 2024-11-08 | -0.21 | +4.0% |
| 2024Q3 | R | per share | 2024-10-28 | -0.22 | -0.5% |
| 2024Q3 | S | per share | 2024-10-26 | 1.14 | 0.0% |
| 2024Q2 | E | per share | 2024-07-28 | -0.20 | 0.0% |
| 2024Q2 | R | per share | 2024-07-28 | -0.23 | 0.0% |
| 2024Q2 | S | per share | 2024-07-27 | 1.22 | 0.0% |
| 2024Q1 | E | per share | 2024-05-10 | -0.24 | +3.4% |
| 2024Q1 | S | per share | 2024-05-10 | 1.05 | -0.4% |
| 2024Q1 | R | per share | 2024-04-26 | -0.28 | +0.4% |
| 2023FY | E | per share | 2024-03-26 | -0.92 | -17.3% |
| 2023FY | R | per share | 2024-03-26 | -1.26 | -0.3% |
| 2023FY | S | per share | 2024-03-26 | 2.43 | -0.7% |
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.03 | -0.12 | -0.224 | -0.804 | -1.553 | -1.261 | -1.05 | -0.692 | -0.4081 | - |
| Sales USD millions | 0 | 0 | 0 | 1 | 0 | 2 | 4 | 5 | 5 | - |
| Shares million shares | 37 | 37 | 37 | 35 | 41 | 42 | 63 | 131 | - | 191 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.246 | -0.198 | -0.524 | -0.08 | -0.096 | -0.124 | -0.169 | -0.08 | -0.035 |
| Sales USD millions | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Shares million shares | 52 | 63 | 84 | 102 | 131 | 131 | 165 | 191 | 191 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.44 | 4.71+8.3% | 4.35+79.0% | 2.43+539.5% | 0.38-24.0% | 0.50 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 7.21 | 7.54-8.8% | 8.27-2.5% | 8.48+52.8% | 5.55+840.7% | 0.59 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.78 | -2.84 | -3.92 | -6.05 | -5.17 | -0.09 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 49.42 | 46.80+11.1% | 42.13-0.7% | 42.43-16.8% | 51.00+86.6% | 27.33+230.1% | 8.28+87.3% | 4.42+291.2% | 1.13 |
| Research and Development | 5.30 | 5.68-5.2% | 5.99-17.4% | 7.25-36.8% | 11.47+23.3% | 9.30+71.0% | 5.44+57.2% | 3.46+380.6% | 0.72 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -51.20 | -49.64 | -46.05 | -48.48 | -56.17 | -27.42 | -8.28 | -4.42 | -1.13 |
| Interest Expense | 0.02 | 0.02-33.3% | 0.03-92.9% | 0.42 | 0.00-100.0% | 0.66 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | -2.36 | 8.73 | -0.23-105.5% | 4.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -48.54 | -58.01 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | -1.13 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -48.54 | -58.01 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | -1.13 |
| Net Income From Continuing Operations | -48.54 | -58.01 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | -1.13 |
| Net Income | -61.29 | -70.57 | -53.02 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | -1.13 |
| EPS (Recurring) per share | -0.33 | -0.63 | -1.05 | -1.19 | -1.55 | -0.80 | -0.22 | -0.12 | -0.03 |
| EPS (Basic, Before Extraordinaries) per share | -0.41 | -0.69 | -1.05 | -1.26 | -1.55 | -0.80 | -0.22 | -0.12 | -0.03 |
| EPS (Diluted) per share | -0.41 | -0.69 | -1.05 | -1.26 | -1.55 | -0.80 | -0.22 | -0.12 | -0.03 |
| EBITDA | -50.32 | -48.77 | -44.88 | -45.98 | -54.23 | -27.41 | -8.28 | -4.42 | -1.13 |
| Non-Operating Income (Expense) | 0.32 | 0.39+21.9% | 0.32-23.8% | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 5.72 | 4.49-0.9% | 4.53-33.6% | 6.82-54.5% | 14.99+56.1% | 9.60+13614.3% | 0.07-58.8% | 0.17+325.0% | 0.04 |
| Price To Sales Ratio ratio | 26.37 | 23.61 | 9.52 | 24.25 | 130.49 | 375.02 | - | - | - |
| Gross Margin % | -32.68 | -60.26 | -90.20 | -249.18 | -1,372.15 | -17.80 | - | - | - |
| Operating Margin % | -941.73 | -1,054.82 | -1,059.64 | -1,996.79 | -14,899.47 | -5,483.80 | - | - | - |
| Net Margin % | -1,127.20 | -1,499.55 | -1,220.09 | -2,169.11 | -14,899.47 | -5,615.60 | - | - | - |
| Shares Outstanding million shares | 190.97 | 131.10+107.9% | 63.07+49.0% | 42.33+4.5% | 40.52+16.0% | 34.92-5.6% | 36.990.0% | 36.990.0% | 36.99 |
| Market Capitalization | 84.61 | 84.61+74.2% | 48.58-18.6% | 59.69+18.6% | 50.34-74.7% | 198.65+3.7% | 191.62 | - | - |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.20-0.8% | 1.47+26.7% | 1.26+51.8% | 1.50+25.0% | 1.21+3.4% | 1.16+18.4% | 0.83-17.0% | 1.20+15.4% |
| Cost of Goods Sold Incl. D&A | 1.63-15.1% | 1.67-6.2% | 1.85+4.5% | 2.07-12.7% | 1.92+1.1% | 1.78-3.3% | 1.77-18.1% | 2.37+13.4% |
| Gross Profit | -0.43 | -0.20 | -0.59 | -0.56 | -0.71 | -0.62 | -0.94 | -1.17 |
| Selling, General and Administrative Excl. Other | 11.85+7.2% | 12.61+17.2% | 11.52-0.2% | 13.45+20.0% | 11.05+0.7% | 10.76+4.3% | 11.54+19.7% | 11.21+7.7% |
| Research and Development | 1.18-7.1% | 1.19-4.8% | 1.21-15.4% | 1.72+18.6% | 1.27-24.0% | 1.25-8.8% | 1.43-4.7% | 1.45-24.5% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -12.28 | -12.80 | -12.11 | -14.01 | -11.76 | -11.38 | -12.49 | -12.38 |
| Interest Expense | 0.00 | 0.00-100.0% | 0.010.0% | 0.010.0% | 0.00 | 0.010.0% | 0.010.0% | 0.010.0% |
| Unusual Expense | -5.54 | -1.04 | 1.86-87.2% | 2.36 | -1.26-265.8% | -6.84 | 14.48 | -0.78 |
| Net Income Before Taxes | -6.68 | -11.69 | -13.91 | -16.27 | -10.40 | -4.44 | -26.91 | -11.54 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -6.68 | -11.69 | -13.91 | -16.27 | -10.40 | -4.44 | -26.91 | -11.54 |
| Net Income From Continuing Operations | -6.68 | -11.69 | -13.91 | -16.27 | -10.40 | -4.44 | -26.91 | -11.54 |
| Net Income | -6.68 | -14.71 | -23.63 | -16.27 | -10.40 | -7.89 | -36.02 | -11.54 |
| EPS (Recurring) per share | -0.06 | -0.08 | -0.16 | -0.11 | -0.10 | -0.13 | -0.38 | -0.21 |
| EPS (Basic, Before Extraordinaries) per share | -0.04 | -0.08 | -0.17 | -0.12 | -0.10 | -0.08 | -0.52 | -0.20 |
| EPS (Diluted) per share | -0.04 | -0.08 | -0.17 | -0.12 | -0.10 | -0.08 | -0.52 | -0.20 |
| EBITDA | -12.05 | -12.58 | -11.89 | -13.80 | -11.54 | -11.16 | -12.27 | -12.15 |
| Non-Operating Income (Expense) | 0.06-40.0% | 0.08-27.3% | 0.070.0% | 0.11+57.1% | 0.10+25.0% | 0.110.0% | 0.070.0% | 0.07-22.2% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.45+26.1% | 1.69+48.2% | 1.41+36.9% | 1.170.0% | 1.15-6.5% | 1.14-5.0% | 1.03+10.8% | 1.17+21.9% |
| Price To Sales Ratio ratio | 26.37 | 35.99 | 31.38 | 30.36 | 24.84 | 26.11 | 24.56 | 11.00 |
| Gross Margin % | -35.41 | -13.23 | -47.05 | -37.57 | -58.30 | -53.48 | -114.01 | -97.74 |
| Operating Margin % | -1,020.45 | -868.45 | -964.49 | -931.58 | -971.02 | -978.85 | -1,508.09 | -1,033.83 |
| Net Margin % | -555.03 | -998.30 | -1,881.21 | -1,081.52 | -858.55 | -678.25 | -4,350.00 | -964.16 |
| Shares Outstanding million shares | 190.97+45.9% | 190.76+87.3% | 164.88+95.4% | 131.10+107.9% | 130.92+153.7% | 101.83+106.4% | 84.37+80.5% | 63.07+49.0% |
| Market Capitalization | 84.61-39.0% | 217.28+74.6% | 203.49+57.2% | 142.90+194.2% | 138.60+215.0% | 124.42+189.5% | 129.42+231.3% | 48.58-18.6% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 34.70+55.2% | 22.36+18.3% | 18.90-15.9% | 22.47-58.1% | 53.66+48681.8% | 0.11-31.3% | 0.16+700.0% | 0.02 |
| Short Term Receivables | 0.64+56.1% | 0.41+925.0% | 0.04+100.0% | 0.02-90.0% | 0.20 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.71-22.8% | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.41-3.4% | 1.46-53.4% | 3.13+68.3% | 1.86-46.1% | 3.45+159.4% | 1.33+478.3% | 0.23 | 0.00 |
| Total Current Assets | 37.47+49.0% | 25.15+14.0% | 22.07-9.4% | 24.36-57.5% | 57.30+3879.2% | 1.44+269.2% | 0.39+1850.0% | 0.02 |
| Net Property, Plant & Equipment | 2.62-29.2% | 3.70+40.2% | 2.64-26.7% | 3.60+271.1% | 0.97 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.32-56.8% | 0.74-47.9% | 1.42-58.7% | 3.44 | - | - | - | 0.00 |
| Other Assets | 0.05-95.6% | 1.130.0% | 1.13+1.8% | 1.11+54.2% | 0.72-5.3% | 0.76+18.8% | 0.64 | 0.00 |
| Total Assets | 40.45+31.7% | 30.71+12.6% | 27.27-16.1% | 32.51-44.9% | 59.00+2594.1% | 2.19+112.6% | 1.03+5050.0% | 0.02 |
| Short Term Debt Incl. Current Port. of LT Debt | 24.89+28.0% | 19.45+29.2% | 15.06+1468.8% | 0.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.97-21.8% | 1.24+7.8% | 1.15+8.5% | 1.06-28.9% | 1.49-27.7% | 2.06+157.5% | 0.80+60.0% | 0.50 |
| Other Current Liabilities | 2.72-3.9% | 2.83-78.5% | 13.18+105.6% | 6.41+131.4% | 2.77-79.7% | 13.66+146.6% | 5.54+855.2% | 0.58 |
| Total Current Liabilities | 28.58+21.5% | 23.52-19.9% | 29.38+248.5% | 8.43+97.9% | 4.26-72.9% | 15.71+147.8% | 6.34+487.0% | 1.08 |
| Long Term Debt | 0.93-48.3% | 1.80+800.0% | 0.20-80.8% | 1.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 29.51+16.5% | 25.32-14.4% | 29.58+212.7% | 9.46+122.1% | 4.26-72.9% | 15.71+147.8% | 6.34+487.0% | 1.08 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 54.27-0.3% | 54.42+192.3% | 18.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -43.34 | -49.03 | -20.94-190.8% | 23.05-57.9% | 54.74 | -13.52 | -5.31 | -1.06 |
| Total Shareholders Equity | 10.94+103.0% | 5.39 | -2.31-110.0% | 23.05-57.9% | 54.74 | -13.52 | -5.31 | -1.06 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 10.94+103.0% | 5.39 | -2.31-110.0% | 23.05-57.9% | 54.74 | -13.52 | -5.31 | -1.06 |
| Total Liabilities & Stockholders Equity | 40.45+31.7% | 30.71+12.6% | 27.27-16.1% | 32.51-44.9% | 59.00+2594.1% | 2.19+112.6% | 1.03+5050.0% | 0.02 |
| Book Value Per Share per share | -0.33 | -0.78 | -0.49-186.0% | 0.57-63.7% | 1.57 | -0.37 | -0.14 | -0.03 |
| Tangible Book Value Per Share per share | -0.33 | -0.79 | -0.53-210.4% | 0.48-69.4% | 1.57 | -0.37 | -0.14 | -0.03 |
| Full-Time Employees people | 82+13.9% | 72+2.9% | 70-5.4% | 74 | - | - | - | - |
| Price to Book Ratio ratio | 7.27 | -0.85 | -5.39 | 1.83 | 3.43 | -7.90 | - | - |
| Return on Assets % | -163.04 | -157.04 | -176.20 | -122.77 | -91.77 | -512.86 | -840.65 | - |
| Return on Equity % | -710.60 | -2,956.43 | -507.97 | -144.42 | -136.23 | - | - | - |
| Return on Invested Capital % | -489.00 | -633.14 | - | -233.23 | -51.29 | - | - | - |
| Quick Ratio ratio | 1.29 | 1.03 | 0.75 | 2.89 | 13.45 | 0.09 | 0.06 | 0.02 |
| Current Ratio ratio | 1.31 | 1.07 | 0.75 | 2.89 | 13.45 | 0.09 | 0.06 | 0.02 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -48.54 | -58.01 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | -1.13 |
| Depreciation | 0.88 | 0.87-25.6% | 1.17-53.2% | 2.50+28.9% | 1.94 | 0.00 | - | - | - |
| Other Funds (Non Cash) | 3.41 | 13.46+189.5% | 4.65-60.2% | 11.68-25.3% | 15.64+62.9% | 9.60+13614.3% | 0.07-58.8% | 0.17-41.4% | 0.29 |
| Funds from Operations | -44.24 | -43.68 | -39.71 | -38.49 | -38.59 | -18.48 | -8.21 | -4.25 | -0.83 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -7.28 | -2.81 | -4.43-178.1% | 5.67-36.4% | 8.91+1000.0% | 0.81-68.7% | 2.59+37.0% | 1.89+162.5% | 0.72 |
| Cash from Operating Activities | -51.53 | -46.48 | -44.14 | -32.82 | -29.68 | -17.67 | -5.63 | -2.36 | -0.11 |
| Capital Expenditures | -0.30 | -0.20 | -0.65 | -0.22 | -0.91 | -0.86 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | -3.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.30 | -0.20 | -0.65 | -0.22 | -4.11 | -0.86 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 22.51 | 58.67+94.0% | 30.25+2.7% | 29.46+1028.7% | 2.61-96.6% | 77.74+1293.2% | 5.58+123.2% | 2.50+1823.1% | 0.13 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 22.51 | 58.67+94.0% | 30.25+2.7% | 29.46+1028.7% | 2.61-96.6% | 77.74+1293.2% | 5.58+123.2% | 2.50+1823.1% | 0.13 |
| Proceedsfrom Stock Options | 22.28 | 58.38+93.0% | 30.25+2.7% | 29.46+1434.4% | 1.92-97.5% | 77.74+1293.2% | 5.58+123.2% | 2.50+1823.1% | 0.13 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.36-98.0% | 18.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -5.66 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -5.66 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 22.49 | 59.03+22.3% | 48.25+63.8% | 29.46+1028.7% | 2.61-96.4% | 72.08+1191.8% | 5.58+123.2% | 2.50+1823.1% | 0.13 |
| Net Change in Cash | -29.34 | 12.35+256.9% | 3.46 | -3.58 | -31.18-158.2% | 53.55 | -0.05-135.7% | 0.14+600.0% | 0.02 |
| Free Cash Flow | -51.83 | -46.68 | -44.44 | -33.04 | -30.59 | -18.53 | -5.63 | -2.36 | -0.11 |
| Preferred Dividends (Cash Flow) | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 17.99-62.0% | 33.40+7.3% | 27.88+10.5% | 34.70+55.2% | 47.33+226.6% | 31.12+24.9% | 25.24+1.9% | 22.36+18.3% |
| Short Term Receivables | 0.84+52.7% | 1.09+194.6% | 0.69+1050.0% | 0.64+56.1% | 0.55+1275.0% | 0.37+131.3% | 0.06+20.0% | 0.41+925.0% |
| Inventories | 0.80-7.0% | 0.87-11.2% | 1.00-7.4% | 0.71-22.8% | 0.86-17.3% | 0.98-21.6% | 1.08+68.8% | 0.92 |
| Other Current Assets | 6.33+475.5% | 1.26-7.4% | 1.80+55.2% | 1.41-3.4% | 1.10-12.7% | 1.36-16.0% | 1.16-45.5% | 1.46-53.4% |
| Total Current Assets | 25.96-47.9% | 36.62+8.2% | 31.36+13.9% | 37.47+49.0% | 49.84+196.3% | 33.83+21.0% | 27.54-0.1% | 25.15+14.0% |
| Net Property, Plant & Equipment | 1.88-34.7% | 2.21-30.7% | 2.50-28.4% | 2.62-29.2% | 2.88-24.2% | 3.19-22.0% | 3.49+53.1% | 3.70+40.2% |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.00-100.0% | 0.10-81.1% | 0.21-66.7% | 0.32-56.8% | 0.42-50.0% | 0.53-44.2% | 0.63-40.0% | 0.74-47.9% |
| Other Assets | 0.01-80.0% | 0.01-99.1% | 0.01-99.1% | 0.05-95.6% | 0.05-95.6% | 1.12-0.9% | 1.130.0% | 1.130.0% |
| Total Assets | 27.86-47.6% | 38.95+0.7% | 34.08+3.9% | 40.45+31.7% | 53.20+135.4% | 38.67+13.4% | 32.80+2.3% | 30.71+12.6% |
| Short Term Debt Incl. Current Port. of LT Debt | 18.21-21.4% | 24.41-6.7% | 26.11-22.5% | 24.89+28.0% | 23.18+109.8% | 26.17+116.6% | 33.67+140.5% | 19.45+29.2% |
| Accounts Payable | 1.01+34.7% | 0.67-19.3% | 1.08+30.1% | 0.97-21.8% | 0.75-34.2% | 0.83-7.8% | 0.83-14.4% | 1.24+7.8% |
| Other Current Liabilities | 2.42+6.1% | 2.44+0.8% | 2.20+6.3% | 2.72-3.9% | 2.28+10.7% | 2.42-19.1% | 2.07-58.7% | 2.83-78.5% |
| Total Current Liabilities | 21.65-17.4% | 27.52-6.5% | 29.39-19.6% | 28.58+21.5% | 26.21+83.9% | 29.43+84.2% | 36.57+83.0% | 23.52-19.9% |
| Long Term Debt | 0.28-75.9% | 0.50-63.8% | 0.69-56.9% | 0.93-48.3% | 1.16-42.3% | 1.38-35.8% | 1.60+788.9% | 1.80+800.0% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 21.93-19.8% | 28.02-9.1% | 30.08-21.2% | 29.51+16.5% | 27.36+68.3% | 30.81+69.9% | 38.17+89.4% | 25.32-14.4% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00-100.0% | 0.00-100.0% | 10.13-81.4% | 54.27-0.3% | 54.27-3.0% | 54.42-2.7% | 54.42+22.9% | 54.42+192.3% |
| Common Equity | 5.93 | 10.93 | -6.13 | -43.34 | -28.44 | -46.56 | -59.80 | -49.03 |
| Total Shareholders Equity | 5.93-77.1% | 10.93+39.1% | 4.00 | 10.94+103.0% | 25.84+307.6% | 7.86-50.8% | -5.38-145.2% | 5.39 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 5.93-77.1% | 10.93+39.1% | 4.00 | 10.94+103.0% | 25.84+307.6% | 7.86-50.8% | -5.38-145.2% | 5.39 |
| Total Liabilities & Stockholders Equity | 27.86-47.6% | 38.95+0.7% | 34.08+3.9% | 40.45+31.7% | 53.20+135.4% | 38.67+13.4% | 32.80+2.3% | 30.71+12.6% |
| Book Value Per Share per share | 0.03 | 0.06 | -0.04 | -0.33 | -0.22 | -0.46 | -0.71 | -0.78 |
| Tangible Book Value Per Share per share | 0.03 | 0.06 | -0.04 | -0.33 | -0.22 | -0.46 | -0.72 | -0.79 |
| Full-Time Employees people | - | - | - | 82+13.9% | - | - | - | 72+2.9% |
| Price to Book Ratio ratio | 7.27 | -28.76 | -3.48 | -5.02 | -2.21 | -1.62 | -1.92 | -0.85 |
| Return on Assets % | -119.77 | -134.66 | -134.61 | -163.04 | -140.60 | -151.85 | -190.69 | -157.04 |
| Return on Equity % | -305.59 | -556.27 | - | -710.60 | -331.24 | -463.56 | -1,897.35 | -2,956.43 |
| Return on Invested Capital % | -107.50 | -102.25 | -296.25 | -137.12 | -38.52 | -48.02 | - | -160.49 |
| Quick Ratio ratio | 1.16 | 1.30 | 1.03 | 1.29 | 1.87 | 1.12 | 0.72 | 1.03 |
| Current Ratio ratio | 1.20 | 1.33 | 1.07 | 1.31 | 1.90 | 1.15 | 0.75 | 1.07 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6.68 | -11.69 | -13.91 | -16.27 | -10.40 | -4.44 | -26.91 | -11.54 |
| Depreciation | 0.23+4.5% | 0.220.0% | 0.220.0% | 0.21-4.5% | 0.22+4.8% | 0.22-4.3% | 0.22-56.0% | 0.22-65.1% |
| Other Funds (Non Cash) | -4.09 | 0.68 | 3.30-78.8% | 3.52+618.4% | -0.02-100.9% | -5.62-564.5% | 15.58+1777.1% | 0.49+16.7% |
| Funds from Operations | -10.54 | -10.78 | -10.39 | -12.53 | -10.20 | -9.84 | -11.11 | -10.82 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -5.01 | -0.52 | -1.71 | -0.04-104.2% | -0.69 | -0.71 | -1.36 | 0.95 |
| Cash from Operating Activities | -15.55 | -11.30 | -12.10 | -12.58 | -10.89 | -10.55 | -12.46 | -9.87 |
| Capital Expenditures | -0.02 | -0.02 | -0.21 | -0.05 | -0.03 | -0.03 | -0.09 | -0.26 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.02 | -0.02 | -0.21 | -0.05 | -0.03 | -0.03 | -0.09 | -0.26 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.16-99.4% | 16.85+2.4% | 5.50-63.5% | 0.00 | 27.13+30044.4% | 16.46+41.5% | 15.08-18.6% | 0.00-100.0% |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.16-99.4% | 16.85+2.4% | 5.50-63.5% | 0.00 | 27.13+30044.4% | 16.46+41.5% | 15.08-18.6% | 0.00-100.0% |
| Proceedsfrom Stock Options | 0.16-99.4% | 16.84+2.4% | 5.27-64.7% | 0.00-100.0% | 27.00 | 16.45+41.4% | 14.93-17.8% | 0.45-91.9% |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00 | 0.36 | 18.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.16-99.4% | 16.85+2.4% | 5.49-64.4% | 0.00-100.0% | 27.13+30044.4% | 16.46+41.5% | 15.44-16.6% | 18.00+260.0% |
| Net Change in Cash | -15.41-195.1% | 5.53-6.0% | -6.83-337.2% | -12.63-260.5% | 16.21 | 5.88+3820.0% | 2.88-50.9% | 7.87 |
| Free Cash Flow | -15.57 | -11.32 | -12.32 | -12.63 | -10.92 | -10.57 | -12.56 | -10.13 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Surgical & Medical Instruments & Apparatus | 4.35 | 4.71 | +8.3% | 100.0% |
| Total | 4.35 | 4.71 | +8.3% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 4.35 | 4.71 | +8.3% | 100.0% |
| Total | 4.35 | 4.71 | +8.3% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 9.36% | 15.0M | 160.2M | 4.85M |
| 2026-10-15 | 8.51% | 13.6M | 160.2M | 1.36M |
| 2026-09-30 | 8.40% | 13.5M | 160.2M | 1.22M |
| 2026-09-15 | 8.01% | 12.8M | 160.2M | 1.42M |
| 2026-08-31 | 7.43% | 11.9M | 160.1M | 1.38M |
| 2026-08-14 | 8.01% | 12.8M | 160.1M | 1.43M |
| 2026-07-31 | 7.58% | 12.1M | 160.0M | 1.40M |
| 2026-07-15 | 6.81% | 10.9M | 160.0M | 1.30M |
| 2026-06-30 | 5.89% | 9.4M | 160.0M | 1.16M |
| 2026-06-15 | 4.64% | 7.4M | 160.0M | 835.12K |
| 2026-05-29 | 3.98% | 6.1M | 153.7M | 811.04K |
| 2026-05-15 | 4.31% | 6.6M | 153.7M | 782.38K |
| 2026-04-30 | 4.44% | 5.9M | 133.8M | 771.55K |
| 2026-04-15 | 4.66% | 6.2M | 133.6M | 1.34M |
| 2026-03-31 | 4.77% | 5.9M | 124.5M | 1.31M |
| 2026-03-13 | 6.29% | 5.8M | 92.2M | 1.32M |
| 2026-02-27 | 7.29% | 6.7M | 92.2M | 1.31M |
| 2026-02-13 | 7.88% | 7.3M | 92.2M | 1.30M |
| 2026-01-30 | 7.60% | 7.0M | 92.3M | 1.26M |
| 2026-01-15 | 4.11% | 3.8M | 92.3M | 654.06K |
Option chain
Expiry 2026-11-13 · underlying 0.41, quoted 13 Nov 08:04 ET · ATM -
Option quotes -. A date on a row is older than the last session (12 Nov). 0 rows.
Implied move — the ATM straddle is not quoted.
Put/call open interest — no calls · Put/call volume — no calls
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | |||||||||||||
Latest SEC filings
30 of 283AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-12, period ended 2026-09-30. 10-K filed 2026-03-25, period ended 2025-12-31. LUCD on EDGAR
page 1 of 10Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 8-K | All annual, quarterly, and current reports | 2026-11-12 | 0001493152-26-051207 index |
| 2026-11-12 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001437749-26-036390 index |
| 2026-10-22 | 8-K | All annual, quarterly, and current reports | 2026-10-21 | 0001493152-26-048114 index |
| 2026-10-16 | 8-K | All annual, quarterly, and current reports | 2026-10-12 | 0001493152-26-047404 index |
| 2026-09-22 | 8-K | All annual, quarterly, and current reports | 2026-09-22 | 0001493152-26-043659 index |
| 2026-08-13 | 8-K | All annual, quarterly, and current reports | 2026-08-13 | 0001493152-26-037596 index |
| 2026-08-12 | 10-Q | All annual, quarterly, and current reports | 2026-06-30 | 0001437749-26-027335 index |
| 2026-06-24 | 8-K | All annual, quarterly, and current reports | 2026-06-24 | 0001493152-26-029943 index |
| 2026-05-21 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-05-20 · transaction | 0001094891-26-000217 index |
| 2026-05-14 | 8-K | All annual, quarterly, and current reports | 2026-05-14 | 0001493152-26-022877 index |
| 2026-05-13 | 10-Q | All annual, quarterly, and current reports | 2026-03-31 | 0001437749-26-016751 index |
| 2026-04-30 | DEFA14A | Proxy materials | no report period | 0001493152-26-020716 index |
| 2026-04-30 | ARS | Proxy materials | 2025-12-31 | 0001493152-26-020711 index |
| 2026-04-30 | DEF 14A | Proxy materials | 2026-04-30 | 0001493152-26-020708 index |
| 2026-04-24 | 8-K | All annual, quarterly, and current reports | 2026-04-24 | 0001493152-26-018926 index |
| 2026-04-24 | 3/A | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-03-23 | 0001094891-26-000204 index |
| 2026-04-23 | 424B5 | Registration statements and prospectuses | no report period | 0001493152-26-018791 index |
| 2026-04-23 | 8-K | All annual, quarterly, and current reports | 2026-04-23 | 0001493152-26-018725 index |
| 2026-04-20 | PRE 14A | Proxy materials | 2026-04-20 | 0001493152-26-018123 index |
| 2026-04-13 | 3 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-03-23 | 0001094891-26-000189 index |
| 2026-04-03 | S-8 | Registration statements and prospectuses | no report period | 0001493152-26-014996 index |
| 2026-04-03 | S-8 | Registration statements and prospectuses | no report period | 0001493152-26-014995 index |
| 2026-03-26 | EFFECT | SEC orders and notices | no report period | 9999999995-26-000944 index |
| 2026-03-26 | 424B5 | Registration statements and prospectuses | no report period | 0001493152-26-012968 index |
| 2026-03-26 | 8-K | All annual, quarterly, and current reports | 2026-03-26 | 0001493152-26-012807 index |
| 2026-03-26 | S-3/A | Registration statements and prospectuses | no report period | 0001493152-26-012729 index |
| 2026-03-25 | CORRESP | Filing review correspondence | no report period | 0001493152-26-012730 index |
| 2026-03-25 | 10-K | All annual, quarterly, and current reports | 2025-12-31 | 0001437749-26-009805 index |
| 2026-02-24 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-02-20 · transaction | 0001094891-26-000083 index |
| 2026-02-24 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-02-20 · transaction | 0001094891-26-000080 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 245.27K | 1 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Alyeska Investment Group, L.P. | 4.36% |
| BlackRock, Inc. | 4.12% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.23% |
| Two Seas Capital LP | 2.95% |
| Aberdeen Group plc | 2.17% |
| MASTERS CAPITAL MANAGEMENT LLC | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% |
| STATE STREET CORP | 1.20% |
| FIRST MANHATTAN CO. LLC. | 1.08% |
| WELLS FARGO & COMPANY/MN | 1.02% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.24% |
| abrdn Healthcare Opportunities Fund | 1.88% |
| iShares Russell 2000 ETF | 1.76% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.92% |
| Fidelity Small Cap Index Fund | 0.78% |
| iShares Russell 2000 Growth ETF | 0.69% |
| VANGUARD RUSSELL 2000 INDEX FUND | 0.42% |
| Fidelity Extended Market Index Fund | 0.39% |
| iShares Micro-Cap ETF | 0.25% |
| Schwab Small-Cap Index Fund | 0.18% |
OakChart. LUCD. Cached 15 minutes. Terms